Cargando…
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity
Neoantigens are among the most intriguing potential immuno-oncology targets because, unlike many cancer targets that are expressed on normal tissues, they are by definition restricted to cancer cells. Medicines directed at common neoantigens such as mutant KRAS are especially interesting because the...
Autores principales: | Tokatlian, Talar, Asuelime, Grace E., Naradikian, Martin S., Mock, Jee-Young, Daris, Mark E., Martin, Aaron D., Toledo Warshaviak, Dora, Kamb, Alexander, Hamburger, Agnes E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973398/ https://www.ncbi.nlm.nih.gov/pubmed/36860694 http://dx.doi.org/10.1158/2767-9764.CRC-21-0165 |
Ejemplares similares
-
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
por: Tokatlian, Talar, et al.
Publicado: (2022) -
HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen
por: Mock, Jee-Young, et al.
Publicado: (2022) -
Re-examination of MAGE-A3 as a T-cell Therapeutic Target
por: Martin, Aaron D., et al.
Publicado: (2021) -
Single variable domains from the T cell receptor β chain function as mono- and bifunctional CARs and TCRs
por: Oh, Julyun, et al.
Publicado: (2019) -
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers
por: Wang, Xueyin, et al.
Publicado: (2021)